New onset diabetes during antihypertensive therapy (Q37147731)

18 August 2017

1 reference

title

New onset diabetes during antihypertensive therapy (English)

1 reference

18 August 2017

Michael H Alderman

1

1 reference

18 August 2017

20 March 2008

1 reference

Journal of Clinical Hypertension

18 August 2017

1 reference

18 August 2017

21

1 reference

18 August 2017

5

1 reference

18 August 2017

493-499

1 reference

Impact of the increasing burden of diabetes on acute myocardial infarction in New York City: 1990-2000.

18 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.17

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.17

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.17

The impact of ACE inhibitors or angiotensin II type 1 receptor blockers on the development of new-onset type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.17

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.17

Effect of ramipril on the incidence of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.17

Adverse prognostic significance of new diabetes in treated hypertensive subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.17

Impact of incident diabetes and incident nonfatal cardiovascular disease on 18-year mortality: the multiple risk factor intervention trial experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.17

Labelling of hypertensives: a review of the data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.17

Thiazide diuretics, potassium, and the development of diabetes: a quantitative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.17

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.17

Long-term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.17

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.17

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.17

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.17

Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.17

7 January 2021

Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.17

7 January 2021

Diabetes and cardiovascular events in hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.17

7 January 2021

Diabetes in treated hypertension is common and carries a high cardiovascular risk: results from a 28-year follow-up

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.17

7 January 2021

Impact of new-onset diabetes mellitus on cardiac outcomes in the Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial population

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.17

7 January 2021

Effect of experimental potassium deficiency on glucose and insulin metabolism

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.17

7 January 2021

Identifiers

DOI

10.1038/AJH.2008.17

1 reference

18 August 2017

1 reference

PubMed ID

18437139